#USA #Medical Devices #Horsham #Biocoat #Surmodics

Biocoat Establishes Surmodics Services & Technologies Division

On December 10, 2025, Biocoat made a pivotal announcement regarding the inception of Surmodics Services & Technologies. This new division is set to carry on the legacy of Biocoat’s operations that remain following its recent merger with Surmodics and the strategic divestiture of certain assets.

Surmodics Services & Technologies is poised to focus on delivering advanced hydrophilic and other coating technologies to medical device manufacturers across the globe. Headquartered in Horsham, Pennsylvania, the division emphasizes a customer-centric approach to ensure close collaboration with device manufacturers throughout each development phase.

A Customer-Centric Approach

The division distinguishes itself with a Project Development and Engineering team holding decades of experience. This expertise enables swift and dependable advancement from preliminary concepts to successful commercialization. As a nimble organization, Surmodics Services & Technologies takes pride in its ability to meet the dynamic needs of its customers, whether they are start-ups or established original equipment manufacturers (OEMs).

Comprehensive Capabilities

Located in Horsham, the division is equipped to provide scalable solutions to a diverse clientele. It encompasses every aspect of product development, including early-stage formulation, feasibility testing, optimization, and full production of coating solutions. By accommodating various developmental stages, Surmodics Services & Technologies is well-positioned to stimulate innovation across the entire lifecycle of medical devices.

CEO Chip Hance commented on this significant milestone, stating, "Today marks a significant milestone for our organization and for the customers we serve. With Surmodics Services & Technologies, we continue with a focused, agile, and innovation-driven division built on decades of scientific excellence." Hance further emphasized that under this new identity, the division aims to strengthen partnerships with device manufacturers to facilitate the introduction of next-generation medical technologies to patients worldwide.

About Surmodics Services & Technologies

Surmodics Services & Technologies specializes in providing advanced hydrophilic coating solutions, custom polymer formulations, and full-service coating operations tailored for the medical device sector. The division's commitment to advancing medical technology remains constant as it partners with start-ups, Contract Development and Manufacturing Organizations (CDMOs), and OEMs to drive innovation and elevate device performance.

About Surmodics, Inc.

Surmodics, Inc. is renowned for its performance coating technologies serving intravascular medical devices and various components for in vitro diagnostic immunoassays and microarrays. In addition to its coating technologies, Surmodics develops differentiated vascular intervention medical devices targeting unmet clinical needs, adhering to the highest engineering requirements. With a mission focused on enhancing disease detection and treatment, Surmodics continues to leverage its expertise in both surface modification and drug-delivery technologies.

For more information, visit www.surmodics.com.

In conclusion, the establishment of Surmodics Services & Technologies marks an exciting chapter for Biocoat, enabling enhanced collaboration with medical device manufacturers while driving the development of innovative medical technologies.